Patterns of Initial Antidementia Medication Prescriptions Among Community-Dwelling Individuals in Norway: A Comprehensive Register-Based Analysis - Top-Institutions - MDSpire

Patterns of Initial Antidementia Medication Prescriptions Among Community-Dwelling Individuals in Norway: A Comprehensive Register-Based Analysis

  • By

  • Torunn Gudmestad Øvrebø

  • Anita L. Sunde

  • Arvid Rongve

  • Svein Reidar Kjosavik

  • Ingvild Dalen

  • Ragnhild Oesterhus

  • March 31, 2026

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Sweden

    Key Differentiators

    • Neurology
    • Geriatrics
    • Pharmacoepidemiology

  • #2

    University of California, San Francisco (UCSF) Memory and Aging Center
    University of California, San Francisco (UCSF) Memory and Aging Center

    San Francisco, California

    Key Differentiators

    • Neurology
    • Geriatric Psychiatry
    • Clinical Pharmacology

  • #3

    University of Oxford, Department of Psychiatry
    University of Oxford, Department of Psychiatry

    Oxford, United Kingdom

    Key Differentiators

    • Psychiatry
    • Neurology
    • Epidemiology

  • #4

    Norwegian Institute of Public Health
    Norwegian Institute of Public Health

    Oslo, Norway

    Key Differentiators

    • Public Health
    • Epidemiology
    • Pharmacoepidemiology

  • #5

    Mayo Clinic, Department of Neurology
    Mayo Clinic, Department of Neurology

    Rochester, Minnesota

    Key Differentiators

    • Neurology
    • Geriatrics
    • Clinical Research

Original Source(s)

Patterns of Initial Antidementia Medication Prescriptions Among Community-Dwelling Individuals in Norway: A Comprehensive Register-Based Analysis

  • by Torunn Gudmestad Øvrebø, Anita L. Sunde, Arvid Rongve, Svein Reidar Kjosavik, Ingvild Dalen, Ragnhild Oesterhus

  • March 31, 2026

Related Content

Lead Exposure Implicated in Rising Alzheimer's Rates

US study finds that patients with high bone lead levels are three times more likely to develop the disease

  • February 19, 2026

  • 2 min
Navigating Healthcare Challenges for Family Caregivers of Individuals with Alzheimer’s Disease and Related Dementias

A new rule puts NIH grant reviewers at risk